Frenkel Ran
CIK 0001623108
EVP, Chief Dev. Officer
Filings
3
Latest Mar 2, 2022
Issuers covered
1
Showing
3 of 3
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 100% | +36.7% | +35.7% | +45.4% | +28.8% |
| 90 days | 3 | 100% | +48.3% | +50.7% | +55.0% | +39.2% |
| 180 days | 3 | 100% | +51.4% | +50.2% | +54.3% | +49.6% |
| 365 days | 3 | 100% | +68.9% | +70.4% | +70.8% | +65.6% |
Issuers
Companies where Frenkel Ran has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | 3 | Mar 2, 2022 |
All filings
3 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|